miRNA dysregulation is an emerging modulator of genomic instability

APF Cardoso, M Banerjee, AN Nail, A Lykoudi… - Seminars in cancer …, 2021 - Elsevier
Genomic instability consists of a range of genetic alterations within the genome that
contributes to tumor heterogeneity and drug resistance. It is a well-established characteristic …

Can microRNA become next-generation tools in molecular diagnostics and therapeutics? A systematic review

V Saini, R Dawar, S Suneja, S Gangopadhyay… - Egyptian Journal of …, 2021 - Springer
Background MicroRNAs (miRNAs) represent a novel class of single-stranded RNA
molecules of 18–22 nucleotides that serve as powerful tools in the regulation of gene …

[HTML][HTML] MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway

X Luo, J Dong, X He, L Shen, C Long, F Liu… - Biomedicine & …, 2020 - Elsevier
Abstract Background MicroRNA-155-5p (miR-155-5p) has been reported to play an
oncogenic role in different human malignancies; however, its role in Wilms tumor (WT) …

Role of microRNAs in Chronic Lymphocytic Leukemia

F Autore, A Ramassone, L Stirparo, S Pagotto… - International Journal of …, 2023 - mdpi.com
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults, with a
highly variable clinical course. Improvement in the knowledge of the molecular pathways …

MicroRNAs in autoimmunity and hematological malignancies

MD Marco, A Ramassone, S Pagotto… - International Journal of …, 2018 - mdpi.com
Autoimmunity and hematological malignancies are often concomitant in patients. A causal
bidirectional relationship exists between them. Loss of immunological tolerance with …

Biosafety evaluation of culture-expanded human chondrocytes with growth factor cocktail: a preclinical study

ME Al-Masawa, WS Wan Kamarul Zaman, KH Chua - Scientific Reports, 2020 - nature.com
The scarcity of chondrocytes is a major challenge for cartilage tissue engineering.
Monolayer expansion is necessary to amplify the limited number of chondrocytes needed for …

Role of non-coding RNAs in the development of targeted therapy and immunotherapy approaches for chronic lymphocytic leukemia

F Pepe, V Balatti - Journal of Clinical Medicine, 2020 - mdpi.com
In the past decade, novel targeted therapy approaches, such as BTK inhibitors and Bcl2
blockers, and innovative treatments that regulate the immune response against cancer cells …

Role of microRNAs in Chronic Lymphocytic Leukemia.

A Ramassone, L Stirparo, S Pagotto… - International …, 2023 - search.ebscohost.com
Abstract Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in
adults, with a highly variable clinical course. Improvement in the knowledge of the molecular …

HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia

S Pagotto, A Veronese, A Soranno, V Balatti… - Cancers, 2019 - mdpi.com
Aneuploidy and overexpression of hsa-miR-155-5p (miR-155) characterize most solid and
hematological malignancies. We recently demonstrated that miR-155 sustains aneuploidy at …

Identification of microRNA editing sites in three subtypes of leukemia

W Xie, J Yang, N Zhou, H Ding, G Zhou… - Frontiers in Molecular …, 2022 - frontiersin.org
Leukemia is an aberrant hyper-proliferation of immature blood cells that do not form solid
tumors. The transcriptomes of microRNAs (miRNAs) of leukemia have been intensively …